SHANGHAI, July 7, 2025 /PRNewswire/ — WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, today announced it has achieved the AAA rating – the highest level – from MSCI in its latest annual Environmental, Social, and Governance (ESG) ratings. This is the first time WuXi AppTec has achieved the AAA rating, making it the first A-share listed company in the life science industry to reach this milestone. This achievement underscores WuXi AppTec’s enduring commitment to sustainability and its belief in driving long-term value through responsible growth for a healthier future.
MSCI is a leading provider of critical decision support tools and services for the global investment community. Its ESG ratings assess companies on financially relevant sustainability risks and opportunities, enabling investors to better understand a company’s sustainable development performance and make more informed investment decisions. The MSCI ESG rating system includes seven levels, from AAA (highest) to CCC (lowest), with AAA and AA considered leader ratings.
WuXi AppTec earned the AAA leader rating for its outstanding performance in areas such as Product Safety and Quality, Human Capital Development, and Corporate Governance. Previously, the company maintained an AA rating for four consecutive years, demonstrating consistent leadership in ESG performance.
“We are honored to receive MSCI’s highest ESG rating,” said Dr. Steve Yang, Co-CEO of WuXi AppTec and Chairman of WuXi AppTec’s ESG Committee. “This recognition reflects our commitment to integrating sustainability across our operations and reaffirms the long-term value we strive to create for all stakeholders. We will continue to pursue high-quality growth through our CRDMO platform and support our customers in developing and delivering innovative therapies to patients worldwide.”
As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec strategically integrates sustainability priorities like most of the customers into its global business operations. The Company has been included in the Dow Jones Sustainability Index (DJSI) for four consecutive years, received an A- Leadership rating in the CDP Climate Change assessment for three years, and has been recognized as an Industry and Regional ESG Top-Rated Company by Morningstar Sustainalytics. WuXi AppTec has also earned an A Leadership rating in the CDP Water Security assessment and a Gold Medal in the EcoVadis sustainability rating.
To further its sustainability commitment, WuXi AppTec has received Science Based Targets initiative (SBTi) validation for its near-term emissions reduction targets. The Company is also a participant in the United Nations Global Compact (UNGC), supporting its ten principles, and a supplier partner of the Pharmaceutical Supply Chain Initiative (PSCI).
About WuXi AppTec
WuXi AppTec is a trusted partner and contributor to the pharmaceutical and life sciences industries, providing R&D and manufacturing services that help advance healthcare innovation. With operations across Asia, Europe, and North America, we offer an integrated, end-to-end services through our unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform. We are privileged to work alongside nearly 6,000 partners across 30+ countries, supporting their efforts to bring breakthrough treatments to patients. Guided by our vision that every drug can be made and every disease can be treated, we are committed to advancing breakthroughs for patients—one collaboration at a time. Learn more at www.wuxiapptec.com.
